Literature DB >> 22293019

Budget impact analysis of switching to darunavir/ritonavir monotherapy for HIV-infected people in Spain.

Juan Pasquau, Joana Gostkorzewicz, Francisco Ledesma, Anne Anceau, Andrew Hill, Christiane Moecklinghoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22293019     DOI： 10.2165/11598380-000000000-00000

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN： 1175-5652            Impact factor:   2.561


× No keyword cloud information.
  6 in total

1.  Potential for simplification of HIV treatment with boosted protease inhibitor monotherapy.

Authors:  Elena Reina; Ramón San Miguel; Natalia Larrea; Patricia Garcia; Victor Napal
Journal:  Int J Clin Pharm       Date:  2012-09-25

Review 2.  Evaluating the impact of immigration policies on health status among undocumented immigrants: a systematic review.

Authors:  Omar Martinez; Elwin Wu; Theo Sandfort; Brian Dodge; Alex Carballo-Dieguez; Rogeiro Pinto; Scott D Rhodes; Scott Rhodes; Eva Moya; Silvia Chavez-Baray
Journal:  J Immigr Minor Health       Date:  2015-06

3.  Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.

Authors:  Luis F López-Cortés; Manuel A Castaño; Miguel A López-Ruz; María J Rios-Villegas; José Hernández-Quero; Dolores Merino; Patricia Jiménez-Aguilar; Manuel Marquez-Solero; Alberto Terrón-Pernía; Francisco Tellez-Pérez; Pompeyo Viciana; Francisco Orihuela-Cañadas; Zaira Palacios-Baena; David Vinuesa-Garcia; Jose M Fajardo-Pico; Alberto Romero-Palacios; Guillermo Ojeda-Burgos; Juan Pasquau-Liaño
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

4.  Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations.

Authors:  Alicia Gutierrez-Valencia; Maria Trujillo-Rodriguez; Tamara Fernandez-Magdaleno; Nuria Espinosa; Pompeyo Viciana; Luis F López-Cortés
Journal:  J Int AIDS Soc       Date:  2018-02       Impact factor: 5.396

5.  Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain.

Authors:  Josep M Llibre; Gloria Cardona; José R Santos; Angels Andreu; Josep O Estrada; Jordi Ara; Xavier Bonafont; Bonaventura Clotet
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-23

6.  High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.

Authors:  Juan Pasquau; Carmen Hidalgo-Tenorio; María Luisa Montes; Alberto Romero-Palacios; Jorge Vergas; Isabel Sanjoaquín; José Hernández-Quero; Koldo Aguirrebengoa; Francisco Orihuela; Arkaitz Imaz; María José Ríos-Villegas; Juan Flores; María Carmen Fariñas; Pilar Vázquez; María José Galindo; Isabel García-Mercé; Fernando Lozano; Ignacio de Los Santos; Samantha Elizabeth de Jesus; Coral García-Vallecillos
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.